Ono Pharmaceutical Co Ltd

Watch

Share

OPHLY·682736103·US·ADR·Healthcare - Drug Manufacturers - General

OPHLY (Ono Pharmaceutical Co Ltd) is held by 2 institutional investors as of Q2 2026. Largest holders: First Command Advisory Services, Inc. ($34,134), RHUMBLINE ADVISERS ($23,207). Net institutional sentiment: Mixed.

2

Holders

$57,341

Total Value

50% (2)

Consensus

1 buying - 1 selling

13F: Jun 30, 2026Insider & Congress: Updated regularly

Smart Money Verdict

View all

Loading verdict

Institutional (13F)58

Insider (Form 4)63

Activist (13D/13G)42

Congressional (STOCK Act)55

Holder Quality

53

★★★★★

Elite

57

★★★★

Strong

61

★★★

Solid

19

★★

Below

10

★

Weak

Held by 2 funds

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for OPHLY.

Top Holders

Top Holders (2)History

AllNewIncreasedHeldDecreasedExitedFirst report

Checking access…

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
First Command Advisory Services, Inc.	Increased	7,038(+303.1%)	$34,134	0.0%	-2.47%	32
RHUMBLINE ADVISERS	Decreased	4,785(-14.2%)	$23,207	0.0%	-1.72%	0

OPHLYOno Pharmaceutical Co Ltd

1M3M6M1Y3Y5Y

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

Other Healthcare stocks held by institutions

UNHUNITEDHEALTH GROUP INC

417 holders · $300.5B

LLYELI LILLY & CO

416 holders · $881.6B

TMOTHERMO FISHER SCIENTIFIC INC

401 holders · $151.5B

JNJJOHNSON & JOHNSON

398 holders · $415.6B

DHRDANAHER CORP DEL

395 holders · $98.9B

ISRGINTUITIVE SURGICAL INC

394 holders · $111.8B

MRKMERCK & CO INC

391 holders · $230.3B

ABBVABBVIE INC

386 holders · $303.9B

BSXBOSTON SCIENTIFIC CORP

386 holders · $52.4B

ABTABBOTT LABORATORIES

383 holders · $114.2B

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer